Bitter Gourd

Overview

Bitter gourd, also known as Momordica charantia or bitter melon, is a tropical vine vegetable widely consumed in Asian, African, and Caribbean cuisines and traditionally used in various medicinal practices. Research published in the International Journal of Nutrition and related publications examines both the agricultural and clinical dimensions of this plant. Studies have investigated the morphological characteristics and yield potential of bitter gourd cultivation, including experimental approaches to crop enhancement. Clinical research has focused on the potential application of bitter gourd for managing blood glucose levels in individuals with type 2 diabetes mellitus, reflecting long-standing traditional uses of the plant for glycemic control. Additional comparative studies have explored the hypolipidemic effects of bitter gourd extract in animal models, examining its influence on lipid profiles in comparison to conventional pharmaceutical interventions such as statins. This body of research addresses the growing scientific interest in understanding how traditional food plants may contribute to metabolic health management, particularly for conditions like diabetes and dyslipidemia that represent significant global health challenges. The investigation of bitter gourd spans from agricultural optimization to potential therapeutic applications, bridging nutritional science with clinical outcomes.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 3 articles above have been cited 9 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• Food-Derived Antidiabetic Peptides as Multi-Target Systemic Regulators: A Comprehensive Review of Sources, Preparation, Mechanisms and Future Perspectives
  2026 · Foods
• Antidiabetic Activity of Momordica charantia Extracts Through Incretin Pathway in Streptozotocin-Nicotinamide Induced Diabetic Rat Depends on Dose Differences
  M. Romdhoni et al. · 2025 · Avicenna journal of medical biotechnology
• New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review
  2023 · International Journal of Biological Macromolecules
• New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review
  2023 · International Journal of Biological Macromolecules
• Momordica charantia (bitter gourd), a potent antidiabetic phytomedicine
  2023 · International Journal of Pharmacognosy and Chemistry
• A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods
  2022 · Food Production, Processing and Nutrition
• A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods
  2022 · Food Production Processing and Nutrition
• Hypolipidemic, hepatoprotective, nephroprotective and anti-lipid peroxidation properties of a methanol extract of Paullinia pinnata root-bark, in alloxan-induced hyperglycemic rats
  2019 · Current Issues in Pharmacy and Medical Sciences

A sample of recent works citing this journal's research on Bitter Gourd, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics